Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.
整合蛋白质组学和靶向下一代测序揭示了低级别脑膜瘤的相关异质性，并发现 ANXA3 是 NF2 突变脑膜瘤的新靶点
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2025.105814
Shah Maryam, Akther Yeasmin, Adams Claire L, Banton Matthew C, Sharma Vikram, Ercolano Emanuela, Hilton David A, Kurian Kathreena M, Laraba Liyam, Woznica Waldemar, Parkinson David Bryan, de Assis Leandro José, Hanemann Clemens Oliver
